An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

Journal: Nature Communications

Published: 2020-08-06

DOI: 10.1038/s41467-020-17673-9

Affiliations: 107

Authors: 126

Go to article
Institutions Share
NIH National Cancer Institute (NCI), United States of America (USA) 0.12
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0.08
University of Southern California (USC), United States of America (USA) 0.06
Karolinska Institute (KI), Sweden 0.04
University of Oxford, United Kingdom (UK) 0.03
Harvard University, United States of America (USA) 0.03
American Cancer Society (ACS), United States of America (USA) 0.03
University of Cambridge, United Kingdom (UK) 0.03
The Institute of Cancer Research (ICR), United Kingdom (UK) 0.03
The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.03
Imperial College London (ICL), United Kingdom (UK) 0.02
Brigham and Women's Hospital (BWH), United States of America (USA) 0.02
University of Hawai'i at Manoa (UH Mānoa), United States of America (USA) 0.02
Erasmus University Medical Center (Erasmus MC), Netherlands 0.02
University of Bristol (UoB), United Kingdom (UK) 0.02
Oslo University Hospital (OUS), Norway 0.02
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA) 0.02
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.02
Manchester NIHR Biomedical Research Centre (Manchester BRC), United Kingdom (UK) 0.01
Australian Prostate Cancer Research Centre - Queensland (APCRC - Q), Australia 0.01
Centre for Research in Epidemiology and Population Health (CESP), France 0.01
Florida State University (FSU), United States of America (USA) 0.01
Genomix Inc., United States of America (USA) 0.01
Mayo Clinic's Campus in Florida, United States of America (USA) 0.01
John Radcliffe Hospital, United Kingdom (UK) 0.01
University of Surrey, United Kingdom (UK) 0.01
Princess Margaret Cancer Centre, U of T, Canada 0.01
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.01
Translational Research Institute (TRI), Australia 0.01
International Hereditary Cancer Center (IHCC), PMU, Poland 0.01
Biomedical Sciences Group, KU Leuven, Belgium 0.01
Ulm University Medical Center, Germany 0.01
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.01
Addenbrooke's Hospital, United Kingdom (UK) 0.01
Ghent University (UGent), Belgium 0.01
University of Malaya (UM), Malaysia 0.01
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.01
Medical University of Sofia, Bulgaria 0.01
Beckman Research Institute, City of Hope, United States of America (USA) 0.01
Queen Mary University of London (QMUL), United Kingdom (UK) 0.01
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.01
The University of Melbourne (UniMelb), Australia 0.01
University of Washington (UW), United States of America (USA) 0.01
Stanford Medicine, United States of America (USA) 0.01
Stanford University, United States of America (USA) 0.01
Case Western Reserve University (CWRU), United States of America (USA) 0.01
UH Seidman Cancer Center, CWRU, United States of America (USA) 0.01
Cancer Epidemiology Division (CED), Cancer Council Victoria, Australia 0.01
The Christie NHS Foundation Trust, United Kingdom (UK) 0.01
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.01
Queensland University of Technology (QUT), Australia 0.01
German Consortium of Translational Cancer Research (DKTK), Germany 0.01
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.01
Alberta Health Services (AHS), Canada 0.01
UCL, United Kingdom (UK) 0
The University of Manchester (UoM), United Kingdom (UK) 0
UW Medicine, United States of America (USA) 0
Uppsala University (UU), Sweden 0
University of Turku (UTU), Finland 0
Manchester Cancer Research Centre (MCRC), United Kingdom (UK) 0
Health Sciences Center (HSC), Utah, United States of America (USA) 0
George E. Wahlen Department of VA Medical Center, United States of America (USA) 0
Centre for Research on Prostatic Diseases (CeRePP), France 0
Aarhus University (AU), Denmark 0
University of Porto (UP), Portugal 0
The University of Warwick (Warwick), United Kingdom (UK) 0
Portuguese Oncology Institute (IPO), Portugal 0
Turku University Hospital (TYKS), UTU, Finland 0
SWOG Statistics and Data Management Center, United States of America (USA) 0
Aarhus University Hospital, Denmark 0
GRC 5: Oncotype-URO, France 0
USC University Hospital Complex (CHUS), Spain 0
Longyan University, China 0
University of Alberta (U of A), Canada 0
Galician Foundation of Genomic Medicine (FPGMX), Spain 0
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain 0
Genomic Medicine Group (GMX), Spain 0
USC Health Research Institute of Santiago de Compostela (IDIS), Spain 0
UC San Diego Health System, United States of America (USA) 0
International Epidemiology Institute (IEI), United States of America (USA) 0
Copenhagen University Hospital (CUH), Denmark 0
University of Copenhagen (UCPH), Denmark 0
Herlev University Hospital, Denmark 0
Gentofte University Hospital, Denmark 0
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain 0
Hospital del Mar Medical Research Institute (IMIM), Spain 0
Pompeu Fabra University (UPF), Spain 0
Centre for Research in Environmental Epidemiology (CREAL), ISGlobal, Spain 0

Return